CO-DIAGNOSTICS, INC. — Earnings

Most recent reported period: FY2025 (Q4) (filed for period ending 2025-12-31) · sourced from SEC EDGAR

Next earnings (estimated): Wed, April 1, 2026 30 days overdue (likely already filed but EDGAR cache cold). Anchored to latest quarter-end + 91 days. Analyst-confirmed dates land in a follow-up wave.
YoY = vs same quarter prior year (seasonality-adjusted)

Recent earnings · last 8 quarters

Quarter endRevenueYoYNet IncomeYoYOp. Margin
2025-12-31$264K↑+76.7%
2025-09-30$145K↓-77.3%$-6M↑+39.3%-4824.5%
2025-06-30$163K↓-93.9%$-8M↓-1.7%-4946.1%
2025-03-31$50K↓-89.3%$-8M↑+19.1%-17009.7%
2024-12-31$149K↓-95.8%
2024-09-30$641K↓-73.9%$-10M↓-62.1%-1596.4%
2024-06-30$3M↑+1243.2%$-8M↑+14.8%-289.1%
2024-03-31$468K↓-22.3%$-9M↓-61.8%-2192.9%

Analyst consensus estimates (EPS / Revenue) and implied move from options will land in a follow-up wave. For now, YoY-vs-prior-year-quarter is the surprise proxy.

Last earnings · FY2025 (Q4)

Revenue
$264K
↑+76.7% +$115K YoY

Earnings surprise · last 8 quarters

YoY % change · proxy for analyst surprise until estimates land

EPS history · last 10 fiscal years

diluted, GAAP, annual

Note: EPS reflects WEIGHTED-AVERAGE diluted shares for each fiscal year. Pre-stock- split values can blow up the early bars if SEC's XBRL data isn't split-adjusted — flagged as a known limitation; cumulative split-adjustment is a follow-up.

Margin trends · 39 quarters

margin trajectory tells the operating-leverage story
Gross Margin
46.0%
Operating Margin↓-3228.1pts
-4824.5%
Net Margin↓-2536.9pts
-4049.3%

Go deeper